Skip to main content
Equibles

OPTOMED · Optomed Oyj · Investor Relations

Use OPTOMED with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research OPTOMED.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
1.4560 EUR +0.0240 (+1.68%) At close · Oct 8
Rebalance outlook locked
Market Cap
31.20M EUR
Shares
21.43M

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Upcoming events

Date Event Type
2026-11-06 00:00 UTC Interim Report for 1 January – 30 September 2026 Results publication
2027-02-18 00:00 UTC Financial Statement Bulletin for 1 January – 31 December 2026 Results publication
2027-05-04 00:00 UTC Interim Report for 1 January – 31 March 2027 Results publication
2027-08-12 00:00 UTC Half-Year Financial Report for 1 January – 30 June 2027 Results publication
2027-11-04 00:00 UTC Interim Report for 1 January – 30 September 2027 Results publication

Past events

Date Event Type
2026-08-14 Half-Year Financial Report for 1 January – 30 June 2026 Results publication
2026-05-06 Interim Report for 1 January – 31 March 2026 Results publication
2026-02-10 Financial Statement Bulletin for 1 January – 31 December 2025 Results publication
2025-11-06 Interim Report for 1 January – 30 September 2025 Results publication
2025-08-07 Half-Year Financial Report for 1 January – 30 June 2025 Results publication
2025-05-06 Interim Report for 1 January – 31 March 2025 Results publication
2025-02-13 Financial Statement Bulletin for 1 January – 31 December 2024 Results publication
2024-11-07 Interim Report for 1 January – 30 September 2024 Results publication
2024-08-08 Half-Year Financial Report for 1 January – 30 June 2024 Results publication
2024-05-07 Interim Report for 1 January – 31 March 2024 Results publication
2024-02-15 Financial Statement Bulletin for 1 January – 31 December 2023 Results publication
2023-11-03 Interim Report for 1 January – 30 September 2023 Results publication
2023-08-04 Half-Year Financial Report for 1 January – 30 June 2023 Results publication
2023-05-05 Interim Report for 1 January – 31 March 2023 Results publication
2023-02-17 Financial Statement Bulletin for 1 January – 31 December 2022 Results publication
2022-11-03 Interim Report for 1 January – 30 September 2022 Results publication
2022-09-06 Extraordinary General Meeting 2022 Shareholder meeting
2022-08-04 Half-Year Financial Report for 1 January – 30 June 2022 Results publication
2022-05-10 Annual General Meeting 2022 Shareholder meeting
2022-05-05 Interim Report for 1 January – 31 March 2022 Results publication
2022-03-10 Shareholder's proposals to the Annual General Meeting Shareholder meeting
2022-03-04 Annual Report 2021 Event
2022-02-17 Financial Statement Bulletin 2021 Results publication
2021-11-04 Interim Report for 1 January – 30 September 2021 Results publication
2021-08-05 Half-Year Financial Report for 1 January – 30 June 2021 Results publication

Source: https://www.optomed.com/investors/corporate-responsibility/